Ultra-hypofractionated Radiation Therapy
Showing 1 - 25 of >10,000
Prostate Cancer Trial in Ann Arbor (Ultra-hypofractionated radiation therapy, Moderately Hypo-fractionated Radiation Therapy)
Recruiting
- Prostate Cancer
- Ultra-hypofractionated radiation therapy
- Moderately Hypo-fractionated Radiation Therapy
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Dec 16, 2021
Breast Cancer Female Trial in Novi Sad (Ultra-fractionated radiation therapy)
Recruiting
- Breast Cancer Female
- Ultra-fractionated radiation therapy
-
Novi Sad, Vojvodina, SerbiaOncology Institute of Vojvodina
Jun 19, 2023
Breast Cancer, Radiotherapy Side Effect Trial in Beijing (Ultra-fractionated radiation therapy)
Recruiting
- Breast Cancer
- Radiotherapy Side Effect
- Ultra-fractionated radiation therapy
-
Beijing, ChinaNational Cancer Center/National Clinical Research Center for Can
Mar 9, 2023
Malignant Breast Tumor Trial in Sao Paulo (Ultra-hypofractionated whole breast radiotherapy, Standard Radiation)
Recruiting
- Malignant Breast Neoplasm
- Ultra-hypofractionated whole breast radiotherapy
- Standard Radiation
-
Sao Paulo, SP, BrazilIBCC Oncologia
Dec 26, 2022
Ultra-hypofractionated Radiotherapy in Breast Cancer Patients
Recruiting
- Female Breast Cancer
- ultra-hypofractionated whole breast irradiation
-
Perugia, ItalyRadiation Oncology Section, Department of Medicine and Surgery,
Oct 16, 2022
Prostate Cancer Trial in United States (external beam radiation therapy, brachytherapy, questionnaires)
Active, not recruiting
- Prostate Cancer
- external beam radiation therapy
- +2 more
-
Basking Ridge, New Jersey
- +5 more
Nov 1, 2021
Prostate Cancer Trial in United States (Radiation Therapy)
Recruiting
- Prostate Cancer
- Radiation Therapy
-
Basking Ridge, New Jersey
- +6 more
Nov 16, 2021
Ductal Breast Carcinoma in Situ, Invasive Breast Cancer, Early-stage Breast Cancer Trial in Mérida (Hypofractionated
Recruiting
- Ductal Breast Carcinoma in Situ
- +6 more
- Hypofractionated radiotherapy
-
Mérida, Yucatán, MexicoUnidad Medica de Alta Especialidad
Nov 7, 2022
Lymphoma Trial (Ultra Low Dose 4 Gy Radiation)
Not yet recruiting
- Lymphoma
- Ultra Low Dose 4 Gy Radiation
- (no location specified)
Jun 30, 2023
Soft Tissue Sarcoma Trial in France (Patients will receive the hypofractionated radiation therapy (30 Gy in 5 fractions) prior
Not yet recruiting
- Soft Tissue Sarcoma
- Patients will receive the hypofractionated radiation therapy (30 Gy in 5 fractions) prior to surgery.
- Patient will undergo surgery before receive the adjuvant hypofractionated radiation therapy (40 Gy in 15 fractions).
-
Bordeaux, France
- +10 more
Aug 28, 2023
Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in Scottsdale, Rochester
Active, not recruiting
- Prostate Adenocarcinoma
- +5 more
- Androgen Suppression
- +3 more
-
Scottsdale, Arizona
- +1 more
Jan 5, 2023
Cervical Cancer, Endometrial Cancer Trial (Hypofractionated Image guided External Beam Radiation Therapy (EBRT), Cisplatin,
Not yet recruiting
- Cervical Cancer
- Endometrial Cancer
- Hypofractionated Image guided External Beam Radiation Therapy (EBRT)
- +2 more
- (no location specified)
May 11, 2023
Diffuse Midline Glioma, H3 K27M-Mutant Trial in Rochester (Hypofractionated Radiation Therapy, Quality-of-Life Assessment,
Recruiting
- Diffuse Midline Glioma, H3 K27M-Mutant
- Hypofractionated Radiation Therapy
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 6, 2023
Resectable Soft Tissue Sarcoma, Stage I Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8, Stage IA Soft Tissue Sarcoma
Recruiting
- Resectable Soft Tissue Sarcoma
- +4 more
- Hypofractionated Radiation Therapy
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 5, 2023
Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7 Trial in Scottsdale, Jacksonville,
Active, not recruiting
- Stage I Breast Cancer AJCC v7
- +6 more
- Hypofractionated Radiation Therapy
- +2 more
-
Scottsdale, Arizona
- +2 more
Jan 3, 2023
Hypofractionated Radiation-Induced DNA Damage in Breast Cancer
Not yet recruiting
- Breast Carcinoma
- Invasive Breast Carcinoma
- Biopsy
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Nov 28, 2022
Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Houston (Low Dose Radiation Therapy)
Recruiting
- Recurrent Mantle Cell Lymphoma
- Refractory Mantle Cell Lymphoma
- Low Dose Radiation Therapy
-
Houston, TexasM D Anderson Cancer Center
Jan 30, 2023
Recurrent Endometrial Carcinoma, Unresectable Endometrial Carcinoma Trial in Miami (Lenvatinib, Pembrolizumab, Hypofractionated
Not yet recruiting
- Recurrent Endometrial Carcinoma
- Unresectable Endometrial Carcinoma
- Lenvatinib
- +2 more
-
Miami, FloridaUniversity of Miami
Jan 10, 2023
Non Small Cell Lung Cancer Trial in Sweden (Standard systemic therapy + radiotherapy, Standard systemic therapy)
Not yet recruiting
- Non Small Cell Lung Cancer
- Standard systemic therapy + radiotherapy
- Standard systemic therapy
-
Gothenburg, Sweden
- +5 more
Nov 17, 2023
Metastatic Prostate Adenocarcinoma, Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma Trial in Rochester
Active, not recruiting
- Metastatic Prostate Adenocarcinoma
- +6 more
- Intensity-Modulated Radiation Therapy
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 5, 2023
Lung Cancer Trial in Palo Alto (Hypofractionated accelerated radiation therapy)
Not yet recruiting
- Lung Cancer
- Hypofractionated accelerated radiation therapy
-
Palo Alto, CaliforniaStanford University
Oct 11, 2023
Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma Trial in Houston (other,
Recruiting
- Metastatic Head and Neck Squamous Cell Carcinoma
- Recurrent Head and Neck Squamous Cell Carcinoma
- Hafnium Oxide-containing Nanoparticles NBTXR3
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Meningioma, Meningioma, Adult Trial in Saint Louis (drug, radiation, procedure)
Active, not recruiting
- Meningioma
- Meningioma, Adult
- Avelumab
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Sep 27, 2022
Early Lung Cancer, Stereotactic Body Radiotherapy Trial in Peking (SBRT)
Not yet recruiting
- Early Lung Cancer
- Stereotactic Body Radiotherapy
- SBRT
-
Peking, Beijing, ChinaDepartment of radiation oncology, Peking University Third Hospit
Mar 26, 2023
Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage III Verrucous Carcinoma of the Oral Cavity, Stage IVA
Withdrawn
- Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity
- +6 more
- hypofractionated radiation therapy
- +3 more
-
New Brunswick, New Jersey
- +1 more
Sep 27, 2022